Novartis Pharmaceuticals UK and Oldham PCT, together with a further 7 pharmaceutical companies
To provide a community pharmacist managed cardio vascular health screening and risk assessment service
Joint working partner(s): Novartis Pharmaceuticals and Oldham PCT, NHS Oldham Ellen House Waddington Street Oldham. OL9 6EE, together with a further 7 pharmaceutical companies.
Project Period: From February 2011 for six months.
Joint working project summary:
This is a pilot programme to provide a community pharmacist-managed cardiovascular health screening and risk assessment service. 3-5 community pharmacies will provide this service for a target group of patients, namely people aged 40-70 who have not had a previous diagnosis of cardio-vascular disease.
The objectives of the programme are:
To improve health outcomes and quality of life To reduce health inequalities across the PCT To improve the convenience and accessibility of screening facilities by offering more choice of location and extended hours of availability. To improve access to services To foster closer partnership working between pharmacists, GPs and the Pharmaceutical Industry To utilise the results of this project and the processes applied within it to formulate good practice which will assist Oldham PCT in addressing CVD screening To demonstrate the benefits of working with the Pharmaceutical Industry in this way with a view to identifying further opportunities for companies to work with other PCT members/directorates. To indentify and close gaps in the identification and care of at risk cardiovascular patients. To seek and improve the current system and use the combined skills of the project team (PCT & Industry) to develop possible solutions.
Start date and duration: February 2011 for six months.